Green, C. A., Scarselli, E., Voysey, M., Capone, S., Vitelli, A., Nicosia, A., . . . Pollard, A. J. (2015). Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults. BMJ Open.
Chicago-стиль цитированияGreen, C A., et al. "Safety and Immunogenicity of Novel Respiratory Syncytial Virus (RSV) Vaccines Based On the RSV Viral Proteins F, N and M2-1 Encoded By Simian Adenovirus (PanAd3-RSV) and MVA (MVA-RSV); Protocol for an Open-label, Dose-escalation, Single-centre, Phase 1 Clinical Trial in Healthy Adults." BMJ Open 2015.
MLA-цитированиеGreen, C A., et al. "Safety and Immunogenicity of Novel Respiratory Syncytial Virus (RSV) Vaccines Based On the RSV Viral Proteins F, N and M2-1 Encoded By Simian Adenovirus (PanAd3-RSV) and MVA (MVA-RSV); Protocol for an Open-label, Dose-escalation, Single-centre, Phase 1 Clinical Trial in Healthy Adults." BMJ Open 2015.